# Semmelweis University

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/semmelweis-university/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 58.9 |
| Citations | 3,370,947 |
| City | Budapest |
| Country | HU |
| Description | Semmelweis University is a research organisation in Budapest, HU. OpenAlex records 55,121 works and 3,370,947 citations for it. 13,425 researchers list it as their most recent affiliation. |
| Homepage | http://semmelweis.hu/english/the-university/ |
| OpenAlex ID | https://openalex.org/I101202996 |
| Researchers | 13,425 |
| ROR ID | https://ror.org/01g9ty582 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q277681 |
| Works | 55,121 |

## University papers

Showing 12 of 221.

- [Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging](https://scholariq.org/papers/recommendations-for-cardiac-chamber-quantification-by-echocardiography-in-adults/)
- [Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology](https://scholariq.org/papers/recommendations-for-chamber-quantification-a-report-from-the-american-society-of/)
- [Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines](https://scholariq.org/papers/minimal-information-for-studies-of-extracellular-vesicles-2018-misev2018-a/)
- [Observation of a new particle in the search for the Standard Model Higgs boson with the ATLAS detector at the LHC](https://scholariq.org/papers/observation-of-a-new-particle-in-the-search-for-the-standard-model-higgs-boson/)
- [Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer](https://scholariq.org/papers/pembrolizumab-versus-chemotherapy-for-pd-l1-positive-non-small-cell-lung-cancer/)
- [2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)](https://scholariq.org/papers/2020-esc-guidelines-for-the-diagnosis-and-management-of-atrial-fibrillation/)
- [2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>](https://scholariq.org/papers/2019-esc-eas-guidelines-for-the-management-of-dyslipidaemias-i-lipid/)
- [Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging](https://scholariq.org/papers/recommendations-for-cardiac-chamber-quantification-by-echocardiography-in-adults-2/)
- [2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes](https://scholariq.org/papers/2019-esc-guidelines-for-the-diagnosis-and-management-of-chronic-coronary/)
- [2018 ESC/EACTS Guidelines on myocardial revascularization](https://scholariq.org/papers/2018-esc-eacts-guidelines-on-myocardial-revascularization/)
- [Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction](https://scholariq.org/papers/dapagliflozin-in-patients-with-heart-failure-and-reduced-ejection-fraction/)
- [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC](https://scholariq.org/papers/esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-2/)

## University researchers

- [Béla Merkely](https://scholariq.org/researchers/bela-merkely/)
- [Roberto M. Lang](https://scholariq.org/researchers/roberto-m-lang/)
- [István Ulbert](https://scholariq.org/researchers/istvan-ulbert/)
- [Ulrich‐Frank Pape](https://scholariq.org/researchers/ulrich-frank-pape/)
- [János Réthelyi](https://scholariq.org/researchers/janos-rethelyi/)
- [Miklós Sárdy](https://scholariq.org/researchers/miklos-sardy/)
- [Fanni Rencz](https://scholariq.org/researchers/fanni-rencz/)
- [Nóra Bunford](https://scholariq.org/researchers/nora-bunford/)
- [Tamás Treuer](https://scholariq.org/researchers/tamas-treuer/)
- [Attila Szíjártó](https://scholariq.org/researchers/attila-szijarto/)
- [Mihály Tapolyai](https://scholariq.org/researchers/mihaly-tapolyai/)
- [Pekli Damján](https://scholariq.org/researchers/pekli-damjan/)

## University top topics

Showing 8 of 24.

- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Neuropeptides and Animal Physiology](https://scholariq.org/topics/neuropeptides-and-animal-physiology/)
- [Receptor Mechanisms and Signaling](https://scholariq.org/topics/receptor-mechanisms-and-signaling/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Nitric Oxide and Endothelin Effects](https://scholariq.org/topics/nitric-oxide-and-endothelin-effects/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.